WELL Health Technologies M&A Plans Seen Driving Strong Growth in 2025 -- Market Talk

Dow Jones

Jan 15, 2025

1427 ET - WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts. Kwan says WELL's current M&A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. "With a continued robust M&A pipeline, we believe WELL will remain active with its M&A program that should help it drive strong, profitable growth," Kwan says. Shares are up 1.2% to C$6.70. (adriano.marchese@wsj.com)

(END) Dow Jones Newswires

January 14, 2025 14:27 ET (19:27 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503833316"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503833316\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2503833316?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-15 03:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503833316","market":"fut","top_or_hot":-1,"title":"WELL Health Technologies M&A Plans Seen Driving Strong Growth in 2025 -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1427 ET - WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts. Kwan says WELL's current M&amp;A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. \"With a continued robust M&amp;A pipeline, we believe WELL will remain active with its M&amp;A program that should help it drive strong, profitable growth,\" Kwan says. Shares are up 1.2% to C$6.70. (adriano.marchese@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2025 14:27 ET (19:27 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WELL Health Technologies M&A Plans Seen Driving Strong Growth in 2025 -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWELL Health Technologies M&A Plans Seen Driving Strong Growth in 2025 -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-15 03:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1427 ET - WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts. Kwan says WELL's current M&amp;A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. \"With a continued robust M&amp;A pipeline, we believe WELL will remain active with its M&amp;A program that should help it drive strong, profitable growth,\" Kwan says. Shares are up 1.2% to C$6.70. (adriano.marchese@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2025 14:27 ET (19:27 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WELL","symbol_name":"WELLTOWER OP LLC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2503833316","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503833316","pubTimestamp":1736882820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1427 ET - WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts. Kwan says WELL's current M&A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. \"With a continued robust M&A pipeline, we believe WELL will remain active with its M&A program that should help it drive strong, profitable growth,\" Kwan says. Shares are up 1.2% to C$6.70. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WELL":"WELLTOWER OP LLC","BK4203":"医疗保健房地产投资信托","BK4225":"医疗保健房地产信托","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"WELL Health Technologies并购计划有望推动2025年强劲增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WELL":1},"content_text":"1427 ET - WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts. Kwan says WELL's current M&A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. \"With a continued robust M&A pipeline, we believe WELL will remain active with its M&A program that should help it drive strong, profitable growth,\" Kwan says. Shares are up 1.2% to C$6.70. (adriano.marchese@wsj.com) \n\n\n  (END) Dow Jones Newswires\n\n\n  January 14, 2025 14:27 ET (19:27 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}